SAVA Q4 2024 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$116M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$21M

Operating Income

-$29M

Net Income

-$28M

EPS (Diluted)

$-0.57

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$61M

Free Cash Flow

-$61M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$158M

Total Liabilities

$12M

Stockholders' Equity

$146M

Cash & Equivalents

$129M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$21M	-$19M	-9.6%
Operating Income	-$29M	-$23M	-29.4%
Net Income	-$28M	-$21M	-31.9%